Free Published Scientific Articles by Prof. Muhammad Asim Khan on Ankylosing Spondylitis
1. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der Heijde D. Ann Rheum Dis. 2011 Jun;70(6):896-904.

2. Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. Weber U, Maksymowych WP, Jurik AG, Pfirrmann CW, Rufibach K, Kissling RO, Khan MA, Lambert RG, Hodler J.

Arthritis Rheum. 2009 Jul 15;61(7):893-9. PMID: 19565546 

3. Early spondyloarthritis in an HLA-B27-positive monozygotic twin pair: A highly concordant onset, sites of involvement, and disease course. Weber U, Pfirrmann CW, Kissling RO, Mackenzie CR, Khan MA.
J Rheumatol. 2008 Jul;35(7):1464-6.  PMID: 18609724 

4. Diffuse idiopathic skeletal hyperostosis may give the typical postural abnormalities of advanced ankylosing spondylitis.

Olivieri I, D'Angelo S, Cutro MS, Padula A, Peruz G, Montaruli M, Scarano E, Giasi V, Palazzi C, Khan MA.
Rheumatology (Oxford). 2007 Nov;46(11):1709-11. PMID: 17938137

Akkoc N, Khan MA. Arthritis Rheum. 2005 Dec;52(12):4048-9; author reply 4049-50. No abstract available. PMID: 16320356

6. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, Dougados M, Géher P, Inman RD, Khan MA, Kvien TK, Leirisalo-Repo M, Olivieri I, Pavelka K, Sieper J, Stucki G, Sturrock RD, van der Linden S, Wendling D, Böhm H, van Royen BJ, Braun J; 'ASsessment in AS' international working group; European League Against Rheumatism.
Ann Rheum Dis. 2006 Apr;65(4):442-52. PMID: 16126791

7. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Rudwaleit M, Khan MA, Sieper J. Arthritis Rheum. 2005 Apr;52(4):1000-8. Review. No abstract available. PMID: 15818678

8. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Martin TM, Zhang G, Luo J, Jin L, Doyle TM, Rajska BM, Coffman JE, Smith JR, Becker MD, Mackensen F, Khan MA, Levinson RD, Schumacher HR, Wade NK, Rosenbaum JT, Reveille JD. Arthritis Rheum. 2005 Jan;52(1):269-74.PMID: 15641041

9. Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity. Jin L, Weisman M, Zhang G, Ward M, Luo J, Bruckel J, Inman R, Khan MA, Schumacher HR, Maksymowych WP, Mahowald M, Martin T, Rosenbaum JT, Yu DT, Stone M, Watson J, Dickman E, Davis J, Reveille JD.Rheumatology (Oxford). 2005 Jan;44(1):55-60. Epub 2004 Nov 16.PMID: 15546966

10. Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility. Jin L, Zhang G, Akey JM, Luo J, Lee J, Weisman MH, Bruckel J, Inman RD, Stone MA, Khan MA, Schumacher HR, Maksymowych WP, Mahowald ML, Sawitzke AD, Vasey FB, Yu DT, Reveille JD.
Arthritis Rheum. 2004 Sep;50(9):3047-8. PMID: 15457475

11. Genetic studies in familial ankylosing spondylitis susceptibility. Zhang G, Luo J, Bruckel J, Weisman MA, Schumacher HR, Khan MA, Inman RD, Mahowald M, Maksymowych WP, Martin TM, Yu DT, Stone M, Rosenbaum JT, Newman P, Lee J, McClain JA, West OC, Jin L, Reveille JD.
Arthritis Rheum. 2004 Jul;50(7):2246-54.PMID: 15248224

12. How to diagnose axial spondyloarthritis early. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J.
Ann Rheum Dis. 2004 May;63(5):535-43.PMID: 15082484  

13. Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Pham T, van der Heijde D, Calin A, Khan MA, van der Linden S, Bellamy N, Dougados M; ASAS Working Group.
Ann Rheum Dis. 2003 Sep;62(9):812-6.PMID: 12922951

14. Conventional treatments for ankylosing spondylitis. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J. Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii40-50. PMID: 12381510

15. Staging of patients with ankylosing spondylitis: a preliminary proposal. Braun J, van der Heijde D, Dougados M, Emery P, Khan MA, Sieper J, van der Linden S.
Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii9-23. Review.PMID: 12381507

16. Ankylosing spondylitis: introductory comments on its diagnosis and treatment.
Khan MA. Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii3-7. PMID: 12381505

17. Update on spondyloarthropathies.
Khan MA. Ann Intern Med. 2002 Jun 18;136(12):896-907. PMID: 12069564

18. Total hip arthroplasty in ankylosing spondylitis. Khan MA.
J Rheumatol. 2002 Jun;29(6):1342; author reply 1342. PMID: 12064860

19. Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin. Reynolds TL, Khan MA, van der Linden S, Cleveland RP. Ann Rheum Dis. 1991 Mar;50(3):154-7.PMID: 2015008

20. Serum IgA, acute phase proteins, and glycosylation of alpha 1-acid glycoprotein in ankylosing spondylitis. Mackiewicz A, Khan MA, Reynolds TL, van der Linden S, Kushner I.
Ann Rheum Dis. 1989 Feb;48(2):99-103.PMID: 2467628

21. Sacroiliac joint abnormalities in paraplegics. Khan MA, Kushner I, Freehafer AA.
Ann Rheum Dis. 1979 Aug;38(4):317-9.PMID: 496445

22. Race-related differences in HLA association with ankylosing spondylitis and Reiter's disease in American blacks and whites. Khan MA.
J Natl Med Assoc. 1978 Jan;70(1):41-2.PMID: 702543

  
 
The information posted on this website is not meant to take the place of medical advice from your personal physician or health care professional. We encourage users of our website to discuss all medical questions with their personal physician or specialist, and prior to initiating any change of treatment, medication, or therapy. We also encourage the viewers to discuss these questions with a rheumatologist if they have not done so in the past. We have provided a link to assist you in finding a rheumatologist in your area if your primary care physician is unable to recommend one.